• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Skin Aging Driven by Epigenetic, Mitochondrial, and Immune Dysfunction Across Cutaneous Layers

by
November 19, 2026
in Health
Reading Time: 6 mins read
0
Skin Aging Driven by Epigenetic, Mitochondrial, and Immune Dysfunction Across Cutaneous Layers

Skin Aging Driven by Epigenetic, Mitochondrial, and Immune Dysfunction Across Cutaneous Layers

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Skin aging represents a widespread clinical and biological concern governed by continuous environmental exposure and progressive intrinsic degradation across molecular, cellular, and tissue-wide layers. In a scientific review published in Immunity & Ageing, researchers Jinxuan Su and Hongzhong Jin synthesize emerging evidence showing that cutaneous deterioration is not driven by isolated defects, but by interconnected networks linking upstream epigenetic alterations, metabolic and mitochondrial dysfunction, and a self-reinforcing immunosenescence–inflammaging axis. As the human body’s largest and outermost organ, the skin relies on stringent dermal homeostasis and barrier integrity to withstand chronic environmental insults. When internal genetic and metabolic shifts intersect with external exposures such as ultraviolet radiation and pollution, cutaneous cells undergo progressive structural remodeling and functional decline. By mapping how discrete regulatory pathways converge, the authors detail the multi-tiered architecture that impairs tissue resilience and establish how targeted interventions—ranging from senolytics to immune modulation—can be rationalized.

At the structural and phenotypic level, skin aging diverges into two interrelated yet mechanistically distinct processes: intrinsic chronological aging and extrinsic photoaging. Chronological aging reflects internal metabolic pacing and cellular turnover limits, typically manifesting as fine wrinkles, epidermal thinning, and gradual tissue atrophy driven by telomere attrition, stem-cell exhaustion, and cumulative epigenetic shifts. Extrinsic aging, triggered primarily by solar ultraviolet exposure, pollution, smoking, and exposome-associated oxidative stress, produces coarse wrinkling, severe extracellular matrix breakdown, and irregular pigmentation such as age spots. Despite these divergent phenotypes, both processes share fundamental histological hallmarks, converging on reduced dermal collagen synthesis, fibroblast functional decline, stem cell depletion, and impaired melanogenesis. Furthermore, substantial mechanistic crosstalk links both pathways: ultraviolet radiation accelerates intrinsic aging hallmarks by elevating reactive oxygen species production, enhancing matrix metalloproteinase activity, and promoting the senescence-associated secretory phenotype, while intrinsic antioxidant decline and immunosenescence concurrently heighten vulnerability to external solar damage.

Upstream of cellular execution programs, epigenetic mechanisms function as sensitive responders that translate environmental and metabolic stressors into durable alterations in the cutaneous transcriptional landscape without modifying underlying DNA sequences. Age-associated changes in DNA methylation patterns, captured by emerging epigenetic clocks, reflect biological skin age and track closely with facial wrinkling, epidermal differentiation defects, and photoaging phenotypes. Maintenance of methylation patterns depends on DNA methyltransferases such as DNMT1, which is abundantly expressed in basal-layer progenitor stem cells to guide epidermal lineage commitment; experimental silencing of DNMT1 accelerates fibroblast senescence, while epidermal deletion triggers cGAS-STING inflammatory pathways. Concurrently, DNA hydroxymethylation regulated by Ten-Eleven Translocation enzymes maintains epigenomic plasticity, though TET2 undergoes age-related hypermethylation and repression in epidermal tissue. Restoring this balance through the SIRT4/TET2 pathway demonstrates potential to counteract keratinocyte senescence. Histone modifications, including altered methylation marks, downregulation of protective deacetylases such as HDAC4, and increased incorporation of the senescence biomarker histone variant H2A.J, disrupt chromatin architecture and exacerbate inflammatory transcription in aging epidermis and dermis.

Metabolic signals directly interface with epigenetic machinery through specialized chemical modifications, most notably lactylation, linking nutrient processing to structural skin maintenance. Extracellular lactate transported via MCT1 into dermal fibroblasts promotes KAT8-mediated lactylation of latent transforming growth factor-β binding protein 1 at lysine 752, enhancing TGF-β activation and driving the transcription of COL1A1 and COL3A1 collagen genes. Beyond autonomous fibroblast pathways, lactate mediates macrophage-to-fibroblast communication, where KAT5/KAT8-directed H4K12 lactylation in macrophages stimulates TGF-β1 and TGF-β3 transcription, thereby indirectly promoting collagen synthesis in surrounding fibroblasts under the homeostatic regulation of HDAC3. Beyond histone dynamics, epitranscriptomic plasticity mediated by non-coding RNAs and RNA methylation coordinates cutaneous aging. MicroRNAs such as miR-217, miR-30, and miR-181 accelerate senescence by suppressing autophagy and disturbing mitochondrial homeostasis, whereas decline in miR-146a compromises circadian rhythms and proliferation. Long non-coding RNA networks integrate DNA repair pathways, while age-related declines in global N6-methyladenosine (m6A) modifications and dysregulation of methyltransferases METTL3 and METTL14 modulate fibroblast photoaging and senescence-associated secretory signaling.

At the cellular level, cutaneous deterioration centers on cellular senescence and profound mitochondrial remodeling, especially within dermal fibroblasts and epidermal keratinocytes. Senescent cells display sustained activation of p53/p21, engagement of the p16INK4a–RB axis, elevated senescence-associated β-galactosidase activity, and loss of structural Lamin B1. This arrest is stabilized by severe mitochondrial dysfunction. Because cutaneous tissues possess high metabolic requirements for barrier regeneration, persistent environmental stress depletes mitochondrial DNA, which lacks protective histones. The resulting loss of mitochondrial membrane potential, compromised oxidative phosphorylation, and excessive generation of reactive oxygen species generate a self-amplifying metabolic loop that enforces senescence. Depleted or damaged mitochondrial DNA escapes into the cytosol, activating cGAS-STING and NF-κB pathways to stimulate inflammatory cytokine release. Calcium dysregulation via TRP channels further accelerates reactive oxygen species accumulation and MMP-1 induction, while protective quality control programs, such as PINK1/Parkin- and NIX-mediated mitophagy, decline with age, diminishing the clearance of damaged organelles.

Recent single-cell and spatial transcriptomic investigations demonstrate that cellular senescence within the skin is not a uniform, dispersed event, but a highly organized, cell-type–specific phenomenon concentrated in localized aging niches. Senescent fibroblasts preferentially gather near the dermal–epidermal junction, disrupting regional matrix organization and creating localized pro-inflammatory zones. Fibroblasts exhibit marked transcriptional heterogeneity during aging, progressively losing their lineage-specific identities, priming states, and supportive secretomes. These spatial niches alter paracrine communication: senescent melanocytes secrete reactive oxygen species and inflammatory mediators that suppress adjacent basal keratinocyte proliferation, promoting epidermal thinning, while senescent endothelial cells activate neuroimmune signaling cascades. Stem cell populations are similarly governed by microenvironmental niches. Hair follicle stem cells retain their intrinsic regenerative competence when placed within youthful dermal environments but fail when exposed to aged niches. Furthermore, age-associated disruption of COL17A1-mediated stem-cell fitness sensing permits dysfunctional clones to persist, impairing normal tissue regeneration and heightening susceptibility to cutaneous malignancies.

Tissue-wide degeneration is orchestrated by a tightly coupled immunosenescence–inflammaging axis, wherein diminishing immune surveillance and chronic low-grade inflammation feed into one another. Age-associated immunosenescence weakens the surveillance, recognition, and clearance of damaged cells by innate and adaptive immune populations, permitting senescent cells to persist. In turn, these surviving senescent cells secrete a potent cocktail of senescence-associated secretory phenotype factors, including IL-1β, IL-6, IL-8, IL-18, TNF-α, and matrix metalloproteinases, which drive persistent local inflammation and induce secondary senescence in neighboring healthy cells. As this inflammatory milieu endures, chronic cytokine exposure reshapes immune compartments, impairing Langerhans cell migration and antimicrobial peptide production in the epidermis, depleting naïve T-cell reserves, and weakening natural killer cell cytotoxicity. Macrophage functional shifts exacerbate this cycle, as pro-inflammatory M1 polarization driven by SPRY1 promotes collagen degradation, whereas reparative M2 polarization wanes. Senescent cells also upregulate checkpoint ligands such as PD-L1, actively evading immune clearance by cytotoxic CD8+ T cells.

The immunosenescence–inflammaging axis is further reinforced by compositional shifts in cutaneous and intestinal microbiomes. Microbial aging clocks reveal that aging skin displays reduced overall bacterial diversity, marked by a decline in commensal Cutibacterium species and an expansion of pro-inflammatory taxa including Corynebacterium, Streptococcus, and Staphylococcus, which correlate with impaired epidermal barrier integrity and persistent immune activation. Concurrently, age-related gut dysbiosis reduces populations of beneficial short-chain fatty acid-producing bacteria such as Lactobacillus and Akkermansia muciniphila. Intestinal barrier compromise enables the systemic translocation of pathogen-associated molecular patterns, notably lipopolysaccharide, into circulation. Circulating lipopolysaccharide engages Toll-like receptor 4/NF-κB signaling in distant cutaneous fibroblasts, provoking cytokine release, accelerating collagen degradation via matrix metalloproteinases, and sustaining tissue-level inflammaging. Conversely, beneficial short-chain fatty acids like butyrate and acetate provide immunoregulatory and mitochondrial-protective effects, meaning their loss deprives the skin of essential anti-inflammatory mediators and locks the cutaneous barrier into a chronic inflammatory state.

Translating these multi-tiered mechanisms into therapeutic solutions has stimulated an evolution from superficial cosmetic strategies toward targeted molecular interventions. Epigenetic modulators, including DNMT1 inhibitors like dihydromyricetin and GSK3685032, alongside HDAC inhibitors such as vorinostat, aim to reprogram senescence-associated transcriptional patterns, though clinical utility requires overcoming off-target effects through localized delivery. Senotherapeutic strategies diverge into senolytics, which selectively eliminate senescent cells, and senomorphics, which dampen inflammatory secretomes. Pharmacological inhibition of glutaminase 1 with BPTES exploits metabolic dependencies to induce senescent cell death and restore collagen density, while classical senolytic regimens such as dasatinib plus quercetin, navitoclax, and fisetin diminish senescent cell burdens. Senomorphic agents, including rapamycin, metformin, and nicotinamide mononucleotide, attenuate inflammatory outputs. In parallel, mitochondrial-targeted therapies employ urolithin A and rosmarinic acid to stimulate SIRT3/PINK1/Parkin-mediated mitophagy, while CD38 inhibitors replenish cellular NAD+ pools to preserve bioenergetic capacity under chronic oxidative stress.

Advanced immunological, biological, and lifestyle interventions offer further avenues to disrupt the immunosenescence–inflammaging cascade and support tissue restoration. Engineered immunotherapies, such as lipid-nanoparticle-delivered CAR-T cells directed against senescent markers like uPAR or NKG2DL, alongside immune checkpoint inhibitors targeting PD-L1, seek to restore endogenous immune clearance of persistent senescent cells, although background immunosenescence remains a significant barrier to efficacy. Biologics repurposed from chronic dermatoses, including clinically approved IL-17 inhibitors (secukinumab, ixekizumab) and TNF-α antagonists, demonstrate preclinical efficacy in mitigating epidermal inflammation, preventing matrix metalloproteinase-driven collagen breakdown, and improving barrier repair. Microbiome modulation using topical and oral probiotics, such as Lactobacillus plantarum HY7714, and postbiotic ferments enhances skin elasticity and hydration. Finally, non-pharmacological lifestyle strategies—including Mediterranean dietary patterns, regular aerobic and resistance exercise that enhances dermal thickness, and calorie restriction that prevents advanced glycation end-product accumulation—collectively highlight the translational potential of multi-modal approaches to preserve functional integrity and cutaneous resilience.

Subject of Research: Multilevel molecular, cellular, and immune mechanisms of skin aging and targeted therapeutic strategies

Article Title: Advances in skin aging: integrating epigenetic, cellular, and immune mechanisms for targeted therapy

Article References: Su, J., & Jin, H. (2026). Advances in skin aging: integrating epigenetic, cellular, and immune mechanisms for targeted therapy. Immunity & Ageing, 23(1), Article 35. https://doi.org/10.1186/s12979-026-00578-4

Image Credits: AI Generated

DOI: 10.1186/s12979-026-00578-4

Keywords: skin aging, epigenetics, cellular senescence, mitochondrial dysfunction, inflammaging, immunosenescence, microbiome dysbiosis, DNA methylation, histone modifications, senotherapeutics, mitophagy, CAR-T therapy, interleukin-17, dermal fibroblasts, keratinocytes, extracellular matrix, targeted therapies

News Source: Beatrice Stafford. (November 19, 2026). Skin Aging Driven by Epigenetic, Mitochondrial, and Immune Dysfunction Across Cutaneous Layers. Scienmag.

Tags: CAR-T therapyCellular Senescencedermal fibroblastsDNA Methylationepigeneticsextracellular matrixhistone modificationsimmunosenescenceinflammaginginterleukin-17keratinocytesMicrobiome dysbiosisMitochondrial dysfunctionMitophagysenotherapeuticsskin agingTargeted Therapies
Share12Tweet7Share2ShareShareShare1

Related Posts

Cross-Sectional Study Identifies Knowledge Gaps and Practice Predictors in Obstructive Sleep Apnea

Cross-Sectional Study Identifies Knowledge Gaps and Practice Predictors in Obstructive Sleep Apnea

November 19, 2026
Transient Retinal Infiltrates in Behçet Uveitis Frequently Mimic Infectious Disease

Transient Retinal Infiltrates in Behçet Uveitis Frequently Mimic Infectious Disease

November 19, 2026

Triple Therapy Yields Limited Response in Child With Homozygous Familial Hypercholesterolemia

November 19, 2026

Dietary Supplements Show Limited Evidence for Pediatric Steatotic Liver Disease

November 19, 2026

POPULAR NEWS

  • Single-Cell Study Links SLC2A1-Driven Metabolism to Immune Evasion in Cholangiocarcinoma

    Single-Cell Study Links SLC2A1-Driven Metabolism to Immune Evasion in Cholangiocarcinoma

    29 shares
    Share 12 Tweet 7
  • Deubiquitinase DUB3 Stabilizes GCase and Reduces Neurodegeneration in Parkinson’s Disease Models

    29 shares
    Share 12 Tweet 7
  • HPV16 and HPV18 Infection Associated With High-Grade Cervical Lesions in Study

    29 shares
    Share 12 Tweet 7
  • Southeast Asian Wildlife Disease Surveillance Relies Predominantly on Passive Outbreak Tracking

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cross-Sectional Study Identifies Knowledge Gaps and Practice Predictors in Obstructive Sleep Apnea

Transient Retinal Infiltrates in Behçet Uveitis Frequently Mimic Infectious Disease

Triple Therapy Yields Limited Response in Child With Homozygous Familial Hypercholesterolemia

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.